• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

3M posts Street-beating Q1 results, updates full-year guidance

April 25, 2017 By Sarah Faulkner

3MShares in 3M (NYSE:MMM) rose today after the company met expectations on Wall Street with its 1st quarter results.

The St. Paul, Minn.-based company posted profits of $1.32 billion, or $2.16 per share, on sales of $7.69 billion for the 3 months ended March 31, for bottom-line growth of 3.1% on sales growth of 3.8% compared with the same period last year.

Adjusted to exclude 1-time items, earnings per share were $2.16, ahead of consensus on The Street, where analysts were looking for sales of $7.52 billion.

“The 3M team delivered a strong start to 2017, marked by organic sales growth of 5% – with positive growth in all geographic areas,” chairman, president & CEO Inge Thulin said in prepared remarks. “At the same time, we increased investments across the enterprise to further accelerate growth and improve productivity, while increasing our dividend for the 59th consecutive year. In the 1st quarter we also announced the acquisition of Scott Safety, which will bolster 3M’s already strong position in the personal safety market.”

In the company’s healthcare branch, sales were up 2.3% to $1.4 billion, driven by increases in sales of drug delivery systems and oral care.

3M updated its guidance for 2017, forecasting sales growth to be 2 to 5%, up from previous guidance of 1 to 3%. The company said it expects earnings in the range of $8.70 to $9.05 apiece.

MMM shares were trading at $194.88 apiece today in afternoon trading, up 0.3%.

Filed Under: Featured, MassDevice Earnings Roundup, Pharmaceuticals Tagged With: 3M

IN CASE YOU MISSED IT

  • What the launch of Mobi for Android means for Tandem, people with diabetes
  • Go-Pen wins CE mark for user-fillable insulin pen
  • Tandem wins FDA nod to pair Mobi pump with Android smartphones
  • The top CGM stories of 2025
  • Billie Jean King supports Medtronic Diabetes awareness initiative

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS